These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4173632)

  • 1. [Antibody deficiency due to long-term cytostatic treatment of malignant tumors and acute leukoses in childhood. Indications for gamma globulin therapy].
    Fischer K; Bläker F; Landbeck G
    Monatsschr Kinderheilkd (1902); 1967 Mar; 115(3):94-5. PubMed ID: 4173632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody depression from cytostatic and radiologic treatment].
    Neidhardt M
    Monatsschr Kinderheilkd (1902); 1969 Apr; 117(4):282-4. PubMed ID: 4194276
    [No Abstract]   [Full Text] [Related]  

  • 3. [Quantitative analyses of immune globulins (IgA, IgG, IgM) during cytostatic treatment].
    Bläker F; Fischer K; Landbeck G
    Dtsch Med Wochenschr; 1966 Dec; 91(50):2259-62. PubMed ID: 4162593
    [No Abstract]   [Full Text] [Related]  

  • 4. [Quantitative immunoglobulin determination during long-term cytostatic therapy].
    Freund R; Rauer U; Hitzig WH
    Monatsschr Kinderheilkd (1902); 1969 Sep; 117(9):563-8. PubMed ID: 4319774
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiblastic chemotherapy and immunity in childhood].
    Nigro N; Madon E; Baroncelli PG; Martini Mauri M
    Minerva Pediatr; 1970 May; 22(20):1035-44. PubMed ID: 4102348
    [No Abstract]   [Full Text] [Related]  

  • 6. [New viewpoints concerning leukemia in children. Treatment of complications].
    Vogt D
    Monatsschr Kinderheilkd (1902); 1970 Jan; 118(1):12-3. PubMed ID: 4108680
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor.
    Santachiara R; Maffei R; Martinelli S; Arcari A; Piacentini F; Trabacchi E; Alfieri P; Ferrari A; Leonardi G; Luppi G; Longo G; Vallisa D; Marasca R; Torelli G
    Haematologica; 2008 Aug; 93(8):1252-5. PubMed ID: 18519520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cytostatic agents on cell suspensions of human malignant tumors in the animal experiment].
    Schönfelder M; Gläser A; Dorschner W; Paschke P
    Z Exp Chir; 1973; 6(3):202-4. PubMed ID: 4772908
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immune suppression by antineoplastic agents and oncologic aggravation].
    Nigro N
    Haematol Lat; 1969; 12(3):841-3. PubMed ID: 4097259
    [No Abstract]   [Full Text] [Related]  

  • 10. [New cytostatics and their clinical application (author's transl)].
    Matthias M
    Arch Geschwulstforsch; 1978; 48(5):445-82. PubMed ID: 747516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of immunotherapy in acute parablastic leukosis].
    Aurich G; Plenert W; Zintl F; Polzin G; Blau HJ; Kruse H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(1):21-8. PubMed ID: 4104079
    [No Abstract]   [Full Text] [Related]  

  • 12. [The function of the immune system after the treatment of pediatric malignant diseases].
    Gadó J; Schlick B; Bárány O; Németh J; Müller J; Csóka M; Constantin T; Vonnák E; Böcskei R; Hauser P; Kovács G
    Orv Hetil; 2006 Sep; 147(36):1731-8. PubMed ID: 17087017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can therapeutic measures cause a hepatitis virus infection to become chronic? (author's transl)].
    Müller R
    MMW Munch Med Wochenschr; 1976 May; 118(21):679-82. PubMed ID: 58376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody therapy in hematology and oncology--2].
    Kneba M; Schrader C; Köhne H
    Med Klin (Munich); 2009 Jan; 104(1):28-49. PubMed ID: 19142594
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytostatic drugs. Part 5 (conclusion): Other cytostatically active drugs].
    Sauer H
    Fortschr Med; 1991 Oct; 109(30):619-20. PubMed ID: 1761266
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention and therapy with human gamma globulin].
    Barandun S
    Clin Ter; 1968 Feb; 44(4):347-61. PubMed ID: 4191045
    [No Abstract]   [Full Text] [Related]  

  • 17. [On gamma globulin therapy. The development of gamma globulin preparations for intravenous injection].
    Riva G
    Helv Med Acta; 1963 Nov; 30(4):277-90. PubMed ID: 4168346
    [No Abstract]   [Full Text] [Related]  

  • 18. Synchronization of malignant cell proliferation, host rhythms and timing of cytostatic therapy.
    Micu D
    Rev Roum Med Intern; 1975; 13(1):3-11. PubMed ID: 1215801
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental and clinical adventures with large doses of gamma and other globulins as anticancer agents.
    MOORE GE; SANDBERG A; AMOS DB
    Surgery; 1957 Jun; 41(6):972-83. PubMed ID: 13442864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Agammaglobulinemia and hypersensitivity reaction after repeated injections of gamma globulin].
    Rudkowski Z; Prandota A; Krawczykowa K
    Pediatr Pol; 1971 Mar; 46(3):351-5. PubMed ID: 4102387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.